Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001615774-18-000386

Chief Financial Officer disposed of 13,251 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Peng George · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-15 Other disposition : show line 1 in the form −13,251 87,014 D
Loading xslF345X03/s108740_form4.xml…